Orthofix Medical Inc. (NASDAQ:OFIX) Holdings Trimmed by Clearline Capital LP

Clearline Capital LP lowered its holdings in Orthofix Medical Inc. (NASDAQ:OFIX) by 3.8% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 249,428 shares of the medical device company’s stock after selling 9,766 shares during the period. Clearline Capital LP owned approximately 0.66% of Orthofix Medical worth $3,307,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of OFIX. nVerses Capital LLC acquired a new position in Orthofix Medical during the second quarter valued at $27,000. Quest Partners LLC purchased a new stake in shares of Orthofix Medical in the second quarter worth approximately $64,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Orthofix Medical by 25.5% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,435 shares of the medical device company’s stock worth $125,000 after purchasing an additional 1,919 shares in the last quarter. Arizona State Retirement System acquired a new stake in shares of Orthofix Medical during the second quarter worth approximately $139,000. Finally, XTX Topco Ltd purchased a new position in Orthofix Medical during the second quarter valued at approximately $175,000. Institutional investors and hedge funds own 89.76% of the company’s stock.

Orthofix Medical Stock Down 0.4 %

OFIX stock opened at $15.32 on Friday. The company has a 50 day moving average of $16.40 and a two-hundred day moving average of $14.77. The company has a market cap of $574.94 million, a price-to-earnings ratio of -4.53 and a beta of 1.05. Orthofix Medical Inc. has a 12-month low of $9.57 and a 12-month high of $17.67. The company has a quick ratio of 1.13, a current ratio of 2.48 and a debt-to-equity ratio of 0.24.

Orthofix Medical (NASDAQ:OFIX) last posted its quarterly earnings results on Tuesday, August 6th. The medical device company reported ($0.88) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.30) by ($0.58). The company had revenue of $198.62 million during the quarter, compared to analyst estimates of $195.75 million. Orthofix Medical had a negative return on equity of 20.68% and a negative net margin of 15.61%. On average, equities analysts anticipate that Orthofix Medical Inc. will post -2.13 earnings per share for the current fiscal year.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.